Chemed (NYSE:CHE) Updates FY 2024 Earnings Guidance

Chemed (NYSE:CHE) updated its FY 2024 earnings guidance on Tuesday. The company provided EPS guidance of 23.000-23.150 for the period, compared to the consensus EPS estimate of 23.580. The company issued revenue guidance of -. Chemed also updated its FY24 guidance to $23.00-$23.15 EPS.

Chemed Stock Up 0.9 %

CHE stock traded up $4.71 during trading on Thursday, reaching $540.51. 155,613 shares of the company’s stock were exchanged, compared to its average volume of 84,661. Chemed has a 1-year low of $525.36 and a 1-year high of $654.62. The company’s fifty day moving average price is $586.71 and its 200-day moving average price is $569.04. The firm has a market cap of $8.13 billion, a PE ratio of 27.31, a P/E/G ratio of 2.44 and a beta of 0.44.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed’s dividend payout ratio is 10.11%.

Insider Activity

In other news, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares in the company, valued at $1,991,615.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares in the company, valued at $1,991,615.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,144 shares of company stock worth $4,141,679 over the last 90 days. 3.32% of the stock is currently owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.